Literature DB >> 21309721

Molecular analysis of the RET proto-oncogene key exons in patients with medullary thyroid carcinoma: a comprehensive study of the Iranian population.

Ehsan Alvandi1, Seyed Mohammad Akrami, Mohsen Chiani, Mehdi Hedayati, Babak Noori Nayer, Mohammad Reza Mohajeri Tehrani, Manouchehr Nakhjavani, Mehrdad Pedram.   

Abstract

BACKGROUND: Germ-line mutations of RET proto-oncogene are the known cause of hereditary medullary thyroid carcinoma (MTC), which account for approximately 25% of all MTC cases and occur as multiple endocrine neoplasia type 2 syndromes. Here, we present the first comprehensive genetic screening and analysis of MTC among Iranian families.
METHODS: A total of 55 patients with MTC (male to female ratio=1:1.6; average age of disease onset = 33 ± 13 years) from 53 independent families participated in this study. All of the patients had undergone total thyroidectomy between 1999 and 2006, and 51 of them were clinically characterized as apparently sporadic cases. Genomic DNA samples were obtained and following highly-specific polymerase chain reaction amplification of the 6 RET key exons (10, 11, 13, 14, 15, and 16) were subjected to direct DNA sequencing without a requirement for a purification step.
RESULTS: Sequence analysis revealed that 9 (17.6%) of the apparently sporadic cases (from 8 kindreds) carried an RET germ-line mutation. Of the seven different mutations identified among all of the families studied, five were in the cysteine codons, with Cys634Arg having the highest prevalence (45.5%) among the afflicted families. Mutation carriers have an earlier age of onset (21 ± 6) versus the sporadic cases (37 ± 12).
CONCLUSIONS: This is the first comprehensive genetic screening and analysis of MTC among Iranian families. The results further confirm the need and advantages of DNA sequencing for identification of hereditary MTC cases. There does not seem to be a meaningful correlation between single nucleotide polymorphism patterns and the average age of disease onset. Geographical distribution of the sporadic cases, however, shows a significant concentration toward the Northern regions of the country, noticeably the provinces situated directly to the south of the Caspian Sea.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21309721     DOI: 10.1089/thy.2010.0267

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  10 in total

1.  Genotype-Phenotype Correlation in Indian Patients with MEN2-Associated Pheochromocytoma and Comparison of Clinico-Pathological Attributes with Apparently Sporadic Adrenal Pheochromocytoma.

Authors:  Sendhil Rajan; Ghazala Zaidi; Gaurav Agarwal; Anjali Mishra; Amit Agarwal; Saroj Kanta Mishra; Eesh Bhatia
Journal:  World J Surg       Date:  2016-03       Impact factor: 3.352

Review 2.  Altered Epigenetic Mechanisms in Thyroid Cancer Subtypes.

Authors:  Maryam Zarkesh; Azita Zadeh-Vakili; Fereidoun Azizi; Forough Foroughi; Maziar Mohammad Akhavan; Mehdi Hedayati
Journal:  Mol Diagn Ther       Date:  2018-02       Impact factor: 4.074

3.  A family presenting with multiple endocrine neoplasia type 2B: A case report.

Authors:  Mahnaz Majidi; Vahid Haghpanah; Mahdi Hedayati; Patricia Khashayar; Mohammad Reza Mohajeri-Tehrani; Bagher Larijani
Journal:  J Med Case Rep       Date:  2011-12-20

Review 4.  PI3K/AKT Pathway and Its Mediators in Thyroid Carcinomas.

Authors:  Zahra Nozhat; Mehdi Hedayati
Journal:  Mol Diagn Ther       Date:  2016-02       Impact factor: 4.074

5.  Crude annual incidence rate of medullary thyroid cancer and RET mutation frequency.

Authors:  Sara Milićević; Damijan Bergant; Tina Žagar; Barbara Perić
Journal:  Croat Med J       Date:  2021-04-30       Impact factor: 1.351

6.  Thyroid oncology.

Authors:  Maria João M Bugalho; Nelson Wohllk; Ana O Hoff; Maria E Cabanillas
Journal:  J Thyroid Res       Date:  2011-10-09

7.  Predominant RET Germline Mutations in Exons 10, 11, and 16 in Iranian Patients with Hereditary Medullary Thyroid Carcinoma.

Authors:  Mehdi Hedayati; Marjan Zarif Yeganeh; Sara Sheikhol Eslami; Shekoofe Rezghi Barez; Laleh Hoghooghi Rad; Fereidoun Azizi
Journal:  J Thyroid Res       Date:  2011-06-13

8.  Haplotype Frequency of G691S/S904S in the RET Proto-Onco-gene in Patients with Medullary Thyroid Carcinoma.

Authors:  Sara Sheikholeslami; Marjan Zarif Yeganeh; Laleh Hoghooghi Rad; Hoda Golab Ghadaksaz; Mehdi Hedayati
Journal:  Iran J Public Health       Date:  2014-02       Impact factor: 1.429

9.  Distribution of RET Mutations in Multiple Endocrine Neoplasia 2 in Denmark 1994-2014: A Nationwide Study.

Authors:  Jes Sloth Mathiesen; Jens Peter Kroustrup; Peter Vestergaard; Kirstine Stochholm; Per Løgstrup Poulsen; Åse Krogh Rasmussen; Ulla Feldt-Rasmussen; Mette Gaustadnes; Torben Falck Ørntoft; Thomas van Overeem Hansen; Finn Cilius Nielsen; Kim Brixen; Christian Godballe; Anja Lisbeth Frederiksen
Journal:  Thyroid       Date:  2017-01-13       Impact factor: 6.568

10.  Interaction between CETP polymorphism and dietary insulin index and load in relation to cardiovascular risk factors in diabetic adults.

Authors:  Faezeh Abaj; Masoumeh Rafiee; Fariba Koohdani
Journal:  Sci Rep       Date:  2021-08-05       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.